360 related articles for article (PubMed ID: 33588892)
1. Role of SIK1 in the transition of acute kidney injury into chronic kidney disease.
Hu J; Qiao J; Yu Q; Liu B; Zhen J; Liu Y; Ma Q; Li Y; Wang Q; Wang C; Lv Z
J Transl Med; 2021 Feb; 19(1):69. PubMed ID: 33588892
[TBL] [Abstract][Full Text] [Related]
2. The Long Noncoding RNA-H19 Mediates the Progression of Fibrosis from Acute Kidney Injury to Chronic Kidney Disease by Regulating the miR-196a/Wnt/β-Catenin Signaling.
Dong X; Cao R; Li Q; Yin L
Nephron; 2022; 146(2):209-219. PubMed ID: 34818249
[TBL] [Abstract][Full Text] [Related]
3. Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation.
Qu C; He D; Lu X; Dong L; Zhu Y; Zhao Q; Jiang X; Chang P; Jiang X; Wang L; Zhang Y; Bi L; He J; Peng Y; Su J; Zhang H; Huang H; Li Y; Zhou S; Qu Y; Zhao Y; Zhang Z
J Hepatol; 2016 May; 64(5):1076-1089. PubMed ID: 26778753
[TBL] [Abstract][Full Text] [Related]
4. Selective Wnt/β-Catenin Pathway Activation Concomitant With Sustained Overexpression of miR-21 is Responsible for Aristolochic Acid-Induced AKI-to-CKD Transition.
Kuang Q; Wu S; Xue N; Wang X; Ding X; Fang Y
Front Pharmacol; 2021; 12():667282. PubMed ID: 34122087
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine-2,3-Dioxygenase Activates Wnt/β-Catenin Inducing Kidney Fibrosis after Acute Kidney Injury.
Pan B; Zhang H; Hong Y; Ma M; Wan X; Cao C
Gerontology; 2021; 67(5):611-619. PubMed ID: 34130288
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of miR-382 contributes to renal fibrosis secondary to aristolochic acid-induced kidney injury via PTEN signaling pathway.
Wang X; Xue N; Zhao S; Shi Y; Ding X; Fang Y
Cell Death Dis; 2020 Aug; 11(8):620. PubMed ID: 32796834
[TBL] [Abstract][Full Text] [Related]
7. IL-6 accelerates renal fibrosis after acute kidney injury via DNMT1-dependent FOXO3a methylation and activation of Wnt/β-catenin pathway.
Guo X; Zhu Y; Sun Y; Li X
Int Immunopharmacol; 2022 Aug; 109():108746. PubMed ID: 35569307
[TBL] [Abstract][Full Text] [Related]
8. A potential link between fibroblast growth factor-23 and the progression of AKI to CKD.
Lu Y; Xu S; Tang R; Han C; Zheng C
BMC Nephrol; 2023 Apr; 24(1):87. PubMed ID: 37016338
[TBL] [Abstract][Full Text] [Related]
9. EGFR drives the progression of AKI to CKD through HIPK2 overexpression.
Xu L; Li X; Zhang F; Wu L; Dong Z; Zhang D
Theranostics; 2019; 9(9):2712-2726. PubMed ID: 31131063
[TBL] [Abstract][Full Text] [Related]
10. Sustained Activation of Wnt/β-Catenin Signaling Drives AKI to CKD Progression.
Xiao L; Zhou D; Tan RJ; Fu H; Zhou L; Hou FF; Liu Y
J Am Soc Nephrol; 2016 Jun; 27(6):1727-40. PubMed ID: 26453613
[TBL] [Abstract][Full Text] [Related]
11. Akt1 is involved in renal fibrosis and tubular apoptosis in a murine model of acute kidney injury-to-chronic kidney disease transition.
Kim IY; Song SH; Seong EY; Lee DW; Bae SS; Lee SB
Exp Cell Res; 2023 Mar; 424(2):113509. PubMed ID: 36773738
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-Catenin in Acute Kidney Injury and Progression to Chronic Kidney Disease.
Huffstater T; Merryman WD; Gewin LS
Semin Nephrol; 2020 Mar; 40(2):126-137. PubMed ID: 32303276
[TBL] [Abstract][Full Text] [Related]
13. FIH-1-modulated HIF-1α C-TAD promotes acute kidney injury to chronic kidney disease progression via regulating KLF5 signaling.
Li ZL; Wang B; Lv LL; Tang TT; Wen Y; Cao JY; Zhu XX; Feng ST; Crowley SD; Liu BC
Acta Pharmacol Sin; 2021 Dec; 42(12):2106-2119. PubMed ID: 33658705
[TBL] [Abstract][Full Text] [Related]
14. Blockade of STAT3 signaling alleviates the progression of acute kidney injury to chronic kidney disease through antiapoptosis.
Park JY; Yoo KD; Bae E; Kim KH; Lee JW; Shin SJ; Lee JS; Kim YS; Yang SH
Am J Physiol Renal Physiol; 2022 May; 322(5):F553-F572. PubMed ID: 35311382
[TBL] [Abstract][Full Text] [Related]
15. Upregulated miR-101 inhibits acute kidney injury-chronic kidney disease transition by regulating epithelial-mesenchymal transition.
Zhao JY; Wang XL; Yang YC; Zhang B; Wu YB
Hum Exp Toxicol; 2020 Dec; 39(12):1628-1638. PubMed ID: 32633566
[TBL] [Abstract][Full Text] [Related]
16. Regulation of pericyte metabolic reprogramming restricts the AKI to CKD transition.
Xu C; Hong Q; Zhuang K; Ren X; Cui S; Dong Z; Wang Q; Bai X; Chen X
Metabolism; 2023 Aug; 145():155592. PubMed ID: 37230215
[TBL] [Abstract][Full Text] [Related]
17. Protective role of kallistatin in renal fibrosis via modulation of Wnt/β-catenin signaling.
Yiu WH; Li Y; Lok SWY; Chan KW; Chan LYY; Leung JCK; Lai KN; Tsu JHL; Chao J; Huang XR; Lan HY; Tang SCW
Clin Sci (Lond); 2021 Feb; 135(3):429-446. PubMed ID: 33458750
[TBL] [Abstract][Full Text] [Related]
18. GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition.
Lu M; Wang P; Qiao Y; Jiang C; Ge Y; Flickinger B; Malhotra DK; Dworkin LD; Liu Z; Gong R
Redox Biol; 2019 Sep; 26():101275. PubMed ID: 31349118
[TBL] [Abstract][Full Text] [Related]
19. TNF or EGFR inhibition equally block AKI-to-CKD transition: opportunities for etanercept treatment.
Abdelmageed MM; Kefaloyianni E; Arthanarisami A; Komaru Y; Atkinson JJ; Herrlich A
Nephrol Dial Transplant; 2023 May; 38(5):1139-1150. PubMed ID: 36269313
[TBL] [Abstract][Full Text] [Related]
20. The IRE1/JNK signaling pathway regulates inflammation cytokines and production of glomerular extracellular matrix in the acute kidney injury to chronic kidney disease transition.
Liang Y; Qu L; Liu Z; Liang L; Wang Y; Quan S; Wang Y; Tang L
Mol Biol Rep; 2022 Aug; 49(8):7709-7718. PubMed ID: 35696049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
